Alibaba Health Information Technology Limited (ALBHF) Stock

About Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited is an investment holding company operating in Mainland China and Hong Kong, focusing on a diverse range of pharmaceutical and healthcare services. Its operations encompass direct pharmaceutical sales, a robust e-commerce platform, and various digital healthcare offerings. The company distributes an extensive array of health-related products, including prescription and over-the-counter medications, nutritional supplements, medical devices, and contact lenses. These items are available to both individual consumers and corporate clients through its online storefronts on Tmall.com and its network of physical pharmacy outlets. Furthermore, its e-commerce platform provides a comprehensive selection of pharmaceuticals, general medical and wellness products, health foods, sexual and family planning items, and contact lenses, alongside direct medical and healthcare services. Alibaba Health delivers a suite of digital healthcare services, such as health check-ups, nucleic acid testing, medical consultations, appointment scheduling, vaccinations, and Traditional Chinese Medicine (TCM) services. These are accessible across multiple prominent platforms including Taobao, Tmall, Alipay, its dedicated Dr. Deer APP, Gaode, DingTalk, and Quark. Beyond these core areas, the company's activities extend to tracking solutions, managing network hospitals, providing internet-based healthcare information and technical support, operating virtual hospitals, and offering asset management services. Previously known as CITIC 21CN Company Limited, the company adopted its current name, Alibaba Health Information Technology Limited, in September 2014. Its corporate headquarters are situated in Causeway Bay, Hong Kong.

Alibaba Health Information Technology Limited is headquartered in HK.

Alibaba Health Information Technology Limited (ALBHF) stock trades at $0.45 with a market capitalization of $7.34B. The stock is valued at a price-to-earnings (P/E) ratio of 24.85, price-to-book of 2.71, price-to-sales of 1.40. Over the past 52 weeks the stock has ranged between $0.40 and $0.90, and currently trades 50.0% below its 52-week high. It pays a dividend yielding 24.44%.

On profitability, Alibaba Health Information Technology Limited generates a return on equity (ROE) of 10.95%, return on capital employed of 10.24%, an operating margin of 5.36%, a net profit margin of 5.65%.

Official website: www.alihealth.cn